Search Results - "Den Heijer, Peter"

2-Year Follow-Up of Patients Undergoing Transcatheter Aortic Valve Implantation Using a Self-Expanding Valve Prosthesis by Buellesfeld, Lutz, MD, Gerckens, Ulrich, MD, Schuler, Gerhard, MD, Bonan, Raoul, MD, Kovac, Jan, MD, Serruys, Patrick W., MD, Labinaz, Marino, MD, den Heijer, Peter, MD, Mullen, Michael, MD, Tymchak, Wayne, MD, Windecker, Stephan, MD, Mueller, Ralf, MD, Grube, Eberhard, MD

“…Objectives The purpose of this study was to evaluate the safety, device performance, and clinical outcome up to 2 years for patients undergoing transcatheter…”
Get full text

Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial by Schur, Nadine, Brugaletta, Salvatore, Cequier, Angel, Iñiguez, Andrés, Serra, Antonio, Jiménez-Quevedo, Pilar, Mainar, Vicente, Campo, Gianluca, Tespili, Maurizio, den Heijer, Peter, Bethencourt, Armando, Vazquez, Nicolás, Valgimigli, Marco, Serruys, Patrick W, Ademi, Zanfina, Schwenkglenks, Matthias, Sabaté, Manel

“…Use of everolimus-eluting stents (EES) has proven to be clinically effective and safe in patients with ST-segment elevation myocardial infarction but it…”
Get full text

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial by Smits, Pieter Cornelis, Dr, Hofma, Sjoerd, MD, Togni, Mario, MD, Vázquez, Nicolás, MD, Valdés, Mariano, Prof, Voudris, Vassilis, MD, Slagboom, Ton, MD, Goy, Jean-Jaques, Prof, Vuillomenet, Andre, MD, Serra, Antoni, MD, Nouche, Ramiro Trillo, MD, den Heijer, Peter, MD, van der Ent, Martin, MD

“…Summary Background Drug-eluting stents with durable biocompatible or biodegradable polymers have been developed to address the risk of thrombosis associated…”
Get full text

Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial by Sabaté, Manel, Dr, Brugaletta, Salvatore, MD, Cequier, Angel, MD, Iñiguez, Andrés, MD, Serra, Antonio, MD, Jiménez-Quevedo, Pilar, MD, Mainar, Vicente, MD, Campo, Gianluca, MD, Tespili, Maurizio, MD, den Heijer, Peter, MD, Bethencourt, Armando, MD, Vazquez, Nicolás, MD, van Es, Gerrit Anne, PhD, Backx, Bianca, RN, Valgimigli, Marco, MD, Serruys, Patrick W, Prof

“…Summary Background Data for the safety and efficacy of new-generation drug-eluting stents at long-term follow-up, and specifically in patients with ST-segment…”
Get full text

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System : results from the multicentre, expanded evaluation registry 1-year following CE mark approval by PIAZZA, Nicolo, GRUBE, Eberhard, LABORDE, Jean-Claude, DE JAEGERE, Peter, SERRUYS, Patrick W, GERCKENS, Ulrich, DEN HEIJER, Peter, LINKE, Axel, LUHA, Olev, RAMONDO, Angelo, USSIA, Giampaolo, WENAWESER, Peter, WINDECKER, Stephan

“…To describe the procedural performance and 30-day outcomes following implantation using the 18 Fr CoreValve Revalving System (CRS) as part of the multicentre,…”
Get full text

Left Bundle-Branch Block Induced by Transcatheter Aortic Valve Implantation Increases Risk of Death by HOUTHUIZEN, Patrick, VAN GARSSE, Leen A. F. M, COCCHIERI, Ricardo, BRUEREN, Guus R. G, VAN STRATEN, Albert H. M, HEIJER, Peter Den, BENTALA, Mohamed, VAN OMMEN, Vincent, KLUIN, Jolanda, STELLA, Pieter R, PRINS, Martin H, MAESSEN, Jos G, POELS, Thomas T, PRINZEN, Frits W, JAEGERE, Peter De, DER BOON, Robert M. A. Van, SWINKELS, Ben M, BERG, Jurrien M. Ten, DER KLEY, Frank Van, SCHALIJ, Martin J, BAAN, Jan

“…Transcatheter aortic valve implantation (TAVI) is a novel therapy for treatment of severe aortic stenosis. Although 30% to 50% of patients develop new left…”
Get full text

Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve Implantation by Nijenhuis, Vincent Johan, MD, Bennaghmouch, Naoual, MD, Hassell, Mariella, MD, Baan, Jan, MD, PhD, van Kuijk, Jan Peter, MD, PhD, Agostoni, Pierfrancesco, MD, PhD, van ‘t Hof, Arnoud, MD, PhD, Kievit, Peter C., MD, PhD, Veenstra, Leo, MD, van der Harst, Pim, MD, PhD, van den Heuvel, Ad F.M., MD, PhD, den Heijer, Peter, MD, PhD, Kelder, Johannes C., MD, PhD, Deneer, Vera H., PharmD, PhD, van der Kley, Frank, MD, Onorati, Francesco, MD, PhD, Collet, Jean Philippe, MD, PhD, Maisano, Francesco, MD, PhD, Latib, Azeem, MD, PhD, Huber, Kurt, MD, PhD, Stella, Pieter R., MD, PhD, ten Berg, Jurrien M., MD, PhD

“…Background Despite improving experience and techniques, ischemic and bleeding complications after transcatheter aortic valve implantation (TAVI) remain…”
Get full text

Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry by Colombo, Antonio, Chandrasekhar, Jaya, Aquino, Melissa, Ong, Tiong Kiam, Sartori, Samantha, Baber, Usman, Lee, Michael, Iniguez, Andres, Hajek, Petr, Borisov, Borislav, Atzev, Borislav, Den Heijer, Peter, Coufal, Zdenek, Hudec, Martin, Mates, Martin, Snyder, Clayton, Moalem, Kamilia, Morrell, Deborah, Elmore, Francesca, Rowland, Stephen, Mehran, Roxana

“…The COMBO stent (OrbusNeich Medical, Ft. Lauderdale, Florida) is a new-generation bio-engineered drug eluting stent, combining an abluminal coating of a…”
Get full text

Balloon-Expandable TAVR Bioprostheses: Area or Perimeter Sizing? A Prospective Pilot Study by Halim, Jonathan, den Heijer, Peter, Vos, Jeroen, Schölzel, Bas E., Meuwissen, Martijn, van den Branden, Ben, Baumbach, Andreas, Ijsselmuiden, Alexander J. J.

“…Objective. In TAVR, area sizing is used for balloon-expandable (BE) valves, whereas self-expanding valves are sized to annulus perimeter. For BE valves, this…”
Get full text

Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves by Kawashima, Hideyuki, Wang, Rutao, Mylotte, Darren, Jagielak, Dariusz, De Marco, Frederico, Ielasi, Alfonso, Onuma, Yoshinobu, den Heijer, Peter, Terkelsen, Christian Juhl, Wijns, William, Serruys, Patrick W, Soliman, Osama

“…The aim of the present analysis is to compare the quantitative angiographic aortic regurgitation (AR) after transcatheter aortic valve implantation (TAVI)…”
Get full text

Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study by Baumbach, Andreas, Mullen, Michael, Brickman, Adam M, Aggarwal, Suneil K, Pietras, Cody G, Forrest, John K, Hildick-Smith, David, Meller, Stephanie M, Gambone, Louise, den Heijer, Peter, Margolis, Pauliina, Voros, Szilard, Lansky, Alexandra J

“…This study aimed to evaluate the safety and performance of the TriGuard™ Embolic Deflection Device (EDD), a nitinol mesh filter positioned in the aortic arch…”
Get full text

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: three-year follow-up of the COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) trial by Vlachojannis, Georgios J, Smits, Pieter C, Hofma, Sjoerd H, Togni, Mario, Vázquez, Nicolás, Valdés, Mariano, Voudris, Vassilis, Puricel, Serban, Slagboom, Ton, Goy, Jean-Jacques, den Heijer, Peter, van der Ent, Martin

“…The aim of this analysis was to compare the long-term safety and efficacy of the biodegradable polymer biolimus-eluting stent (BES) with that of the durable…”
Get full text

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial by Spitaleri, Giosafat, Moscarella, Elisabetta, Brugaletta, Salvatore, Pernigotti, Alberto, Ortega-Paz, Luis, Gomez-Lara, Josep, Cequier, Angel, Iñiguez, Andres, Serra, Antonio, Jiménez-Quevedo, Pilar, Mainar, Vicente, Campo, Gianluca, Tespili, Maurizio, den Heijer, Peter, Bethencourt, Armando, Vazquez, Nicolás, Valgimigli, Marco, Serruys, Patrick W., Sabaté, Manel

Get full text

One Year Clinical Outcomes in Patients with Insulin-Treated Diabetes Mellitus and Non-Insulin-Treated Diabetes Mellitus Compared to Non-Diabetics after Deployment of the Bio-Engineered COMBO Stent by Kalkman, Deborah N., MD, Woudstra, Pier, MD, den Heijer, Peter, MD, PhD, Menown, Ian B.A., MD, Erglis, Andrejs, MD, Suryapranata, Harry, MD, PhD, Arkenbout, Karin E., MD, PhD, Iñiguez, Andrés, MD, PhD, van ’t Hof, Arnoud W.J., MD, PhD, Muller, Philippe, MD, Tijssen, Jan G., PhD, de Winter, Robbert J., MD, PhD

“…Abstract Background The COMBO stent is a novel sirolimus-eluting stent with a luminal anti-CD34 + antibody layer to promote vessel healing. No data is…”
Get full text

One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration by Chandrasekhar, Jaya, de Winter, Vera C., Kalkman, Deborah N., Sartori, Samantha, Chandiramani, Rishi, Aquino, Melissa B., de Wilde, Puk, Zeebregts, Doreen, Woudstra, Pier, Beijk, Marcel A., Hájek, Petr, Atzev, Borislav, Hudec, Martin, Ong, Tiong Kiam, Mates, Martin, Borisov, Borislav, Warda, Hazem M., den Heijer, Peter, Wojcik, Jaroslaw, Iniguez, Andres, Coufal, Zdeněk, Lee, Michael, Tijssen, Jan G., Koch, Karel T., Baber, Usman, Dangas, George D., Colombo, Antonio, de Winter, Robbert J., Mehran, Roxana

“…Purpose The COMBO biodegradable polymer sirolimus-eluting stent includes endothelial progenitor cell capture (EPC) technology for rapid endothelialization,…”
Get full text

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients by den Dekker, Wijnand K, Houtgraaf, Jaco H, Onuma, Yoshinobu, Benit, Edouard, de Winter, Robbert J, Wijns, William, Grisold, Manfred, Verheye, Stephan, Silber, Sigmund, Teiger, Emmanuel, Rowland, Stephen M, Ligtenberg, Erik, Hill, Jonathan, Wiemer, Marcus, den Heijer, Peter, Rensing, Benno J, Channon, Keith M, Serruys, Patrick W.J.C, Duckers, Henricus J

“…Abstract Objective To assess the safety and efficacy of the Genous™ endothelial progenitor cell (EPC) capturing stent in conjunction with HmG-CoA-reductase…”
Get full text

Coronary Artery Perforation After Shockwave Intravascular Lithotripsy by Simsek, Cihan, Vos, Jeroen, IJsselmuiden, Alexander, Meuwissen, Martijn, van den Branden, Ben, den Heijer, Peter, Schölzel, Bas E.

“…Severely calcified coronary lesions remain a challenge in current percutaneous coronary interventions. Shockwave intravascular lithotripsy (Shockwave Medical,…”
Get full text

Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease by Vlachojannis, Georgios J., MD, PhD, Smits, Pieter C., MD, PhD, Hofma, Sjoerd H., MD, PhD, Togni, Mario, MD, Vázquez, Nicolás, MD, Valdés, Mariano, MD, Voudris, Vassilis, MD, Slagboom, Ton, MD, Goy, Jean-Jaques, MD, den Heijer, Peter, MD, PhD, van der Ent, Martin, MD, PhD

“…Abstract Objectives This analysis investigates the 5-year outcomes of the biodegradable polymer biolimus-eluting stent (BP-BES) and durable polymer…”
Get full text

Use of Lithotripsy in a Calcified Saphenous Vein Graft by van Gameren, Menno, Vos, Jeroen, IJsselmuiden, Alexander J.J., Van den Branden, Ben J.L., Meuwissen, Martijn, den Heijer, Peter, Schölzel, Bastiaan E.

“…Percutaneous coronary interventions in saphenous vein grafts can pose a variety of challenges, such as severely calcified lesions. If these lesions are…”
Get full text

1-Year Results of the REMEDEE Registry by Woudstra, Pier, MD, Kalkman, Deborah N., MD, den Heijer, Peter, MD, PhD, Menown, Ian B.A., MD, Erglis, Andrejs, MD, Suryapranata, Harry, MD, PhD, Arkenbout, Karin E., MD, PhD, Iñiguez, Andrés, MD, PhD, van't Hof, Arnoud W.J., MD, PhD, Muller, Philippe, MD, Tijssen, Jan G.P., PhD, de Winter, Robbert J., MD, PhD

“…Abstract Objectives This registry evaluated the safety and clinical outcomes of the Combo stent in an all-comers population in routine clinical practice. We…”
Get full text